Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Dagnon Group was a private U.S. limited liability company that appears to have operated primarily as a healthcare and life sciences consulting business rather than a drug developer. Publicly available descriptions indicate it provided executive management, partnership, advisory board, and product development consulting services, and it was engaged by Outlook Therapeutics under a consulting agreement. The company is associated with Terry James Dagnon, an executive with pharmaceutical, medical device, regulatory, quality, and operations experience. Available evidence does not indicate that The Dagnon Group had an internal therapeutic pipeline, proprietary drug assets, or clinical-stage development programs. Colorado business records available through third-party aggregators list the entity as delinquent, suggesting it is not currently active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Dagnon Group.